Ashwagandha for Women: Benefits, Hormones & Safety (2026)

Key Takeaways

Ashwagandha’s benefits for women center on HPA axis modulation — reducing cortisol cascades into improvements in stress-driven insomnia, mood disturbance, and cortisol-mediated weight gain. Dr. Adrian Lopresti at Murdoch University documented significant improvements in sexual function and quality of life in a female-specific sub-analysis of his crossover trial (Lopresti et al., 2019, American Journal of Men’s Health). The American College of Obstetricians and Gynecologists advises against ashwagandha during pregnancy due to insufficient safety data, but for non-pregnant women, the evidence supports ashwagandha as safe at standard KSM-66 doses.

Ashwagandha (Withania somnifera) is an adaptogenic herb that modulates the HPA axis, the hypothalamic-pituitary-adrenal loop controlling your body's stress response. For women, its cortisol-lowering effect cascades into reproductive hormone balance, sleep quality, and mood regulation. Clinical evidence is strongest for stress relief, solid for perimenopause, and preliminary but promising for sexual function and fertility.

Most articles on this topic tell you ashwagandha "balances hormones" and leave it at that. That's not useful. Which hormones? By how much? Based on what study? And does the effect depend on whether you're 28 and stressed or 52 and perimenopausal?

Those distinctions matter, and they're exactly what this guide covers. We're walking through the actual research, study by study, mechanism by mechanism, and be honest about where the evidence is strong versus where people are extrapolating from cortisol data and hoping for the best.

What Does Ashwagandha Do for Women?

For women, ashwagandha's evidence centers on cortisol regulation and sleep: the 27.9% cortisol reduction in the landmark KSM-66 trial (PMID: 23439798) applied across genders. Women-specific research shows improvement in perimenopausal symptoms — hot flashes and mood — at 300–600 mg/day. Avoid during pregnancy due to uterine-stimulant properties.

Chronically elevated cortisol, from work stress, poor sleep, overexercise, or just the unrelenting pace of daily life, disrupts the signaling between your hypothalamus, pituitary gland, and ovaries. A 2025 review by Brendler in Phytotherapy Research mapped the mechanism clearly: when CRH and ACTH remain elevated, cortisol directly suppresses gonadotropin-releasing hormone (GnRH), which reduces downstream secretion of LH and FSH (PubMed). Your body essentially deprioritizes reproduction because the stress signal says "not a safe time." Ovulation becomes irregular. This is the mechanism behind stress-induced amenorrhea, and it's exactly the pathway ashwagandha targets.

Adrian Lopresti, PhD, at Murdoch University, who has led multiple ashwagandha RCTs, reported that the herb's anxiolytic effects appear to be associated with an attenuating effect on HPA-axis activity — meaning ashwagandha doesn't just mask stress, it dials down the cortisol-production machinery itself (Lopresti et al., 2019, PMC).

Withanolides in ashwagandha root, particularly those standardized to ≥5% in KSM-66®, appear to modulate CRH and ACTH secretion, which restores normal GnRH pulsatility downstream. In women who aren't severely stressed, the effect is subtler. But in women running on cortisol fumes? That shift can be dramatic.

What are ashwagandha's benefits for women?

For women, ashwagandha's best-supported benefits are lower stress and cortisol and better sleep. Some evidence points to improved stress-related sexual function and support during perimenopause. It also modestly affects thyroid hormones, which can help or hinder depending on your situation. Use a standardized extract and monitor how you respond.

1. Cortisol and Stress Relief. The Strongest Evidence

Chandrasekhar et al. (2012) ran a double-blind RCT with 64 adults under chronic stress. KSM-66® at 600 mg/day for 60 days reduced serum cortisol by 27.9% compared to placebo (PubMed). Perceived stress scores dropped by 44%. That trial has been cited over 900 times.

A 2025 systematic review and meta-analysis pooled 15 RCTs with 873 participants and confirmed: ashwagandha supplementation at 250–600 mg/day reduces both cortisol levels and anxiety scores (HAM-A) at 8 weeks (PMC). Cortisol reduction was most pronounced in people with higher baseline stress, meaning it's not just taking everyone to the same floor, it's pulling the most stressed individuals back toward baseline.

A separate 2025 meta-analysis found an interesting wrinkle: ashwagandha reduced biological cortisol but did not significantly reduce Perceived Stress Scale (PSS) scores (PubMed). Your body's cortisol drops, but your subjective feeling of being stressed might not change at the same pace. Worth knowing if you're expecting ashwagandha to "feel" like an anti-anxiety drug. It doesn't. Changes are physiological first, perceptual second.

Dr. Andrew Huberman (Stanford neuroscientist) discusses ashwagandha's mechanism for stress and cortisol reduction alongside other evidence-based supplements.

2. Perimenopause and Menopause Symptoms

Gopal et al. (2021) published the first double-blind, placebo-controlled RCT specifically testing ashwagandha in perimenopausal women. 100 women aged 45–60, randomized to 300 mg ashwagandha root extract twice daily or placebo for 8 weeks (PubMed).

Results in the ashwagandha group versus placebo:

• Reduction in hot flashes, night sweats, and heart palpitations
• Improved psychological symptoms, depressed mood, irritability, impaired memory
• Reduced urogenital symptoms including vaginal dryness and low libido
• Serum estradiol rose
• FSH and LH dropped
• No significant adverse events

One trial is not a definitive answer. But it's a well-designed one with a clear mechanism: lower cortisol → less HPA axis interference with ovarian function → improved hormonal milieu. A 2025 review in the Australian Journal of Herbal and Naturopathic Medicine noted that Gopal's study remains the only RCT using menopause-specific outcome measures, while 13 other trials with women-inclusive cohorts provide supporting evidence for the stress-related mechanisms.

If you're in perimenopause and considering ashwagandha, temper expectations: this isn't hormone replacement therapy. It's an adaptogen that may soften the edges. Severe vasomotor symptoms? Talk to your doctor about MHT. Mild to moderate symptoms with a stress component, that's where ashwagandha has the best shot at helping. For more context on the cortisol connection, see our deep dive on ashwagandha and cortisol.

3. Sexual Function and Libido

Dongre et al. (2015) randomized 50 healthy women to 300 mg ashwagandha root extract (KSM-66®) twice daily or placebo for 8 weeks. Measured via the Female Sexual Function Index (FSFI) and Female Sexual Distress Scale (FSDS) (PMC).

The ashwagandha group showed clear improvements in arousal (p < 0.001), lubrication (p < 0.001), orgasm (p = 0.004), satisfaction (p < 0.001), sexual distress scores (p < 0.001), and number of successful sexual encounters (p < 0.001). Fifteen of 25 women rated their response as "excellent."

Why? Chronic stress suppresses libido through both hormonal and neurological channels. Chronic stress suppresses libido through both hormonal (elevated cortisol competing with reproductive pathways) and neurological (sympathetic nervous system dominance) channels.

One pilot study. Fifty participants. Large effect sizes, but no independent replication yet with 50 participants. Effect sizes are large. But nobody has replicated it yet. It's encouraging, not conclusive. If low libido is your primary concern, ashwagandha is worth trying, but don't expect it to override relationship dynamics, hormonal birth control effects, or medical causes of low desire. For more on this topic, see our ashwagandha's effect on libido guide.

4. Sleep Quality

Langade et al. (2021) ran a parallel-group RCT with 80 adults, half healthy, half with insomnia, taking 300 mg of ashwagandha root extract twice daily for 8 weeks. Sleep onset latency dropped. Total sleep time increased. Sleep efficiency improved. And the insomniacs got more out of it than the healthy volunteers, which makes sense: there's more room to improve when you're starting from a worse baseline (PubMed). A 2021 meta-analysis pooling five sleep studies backed this up — small but real effect, with the strongest results at 600 mg/day taken for at least 8 weeks.

Lower evening cortisol = better sleep architecture. That's the whole mechanism. Your body wasn't designed to produce melatonin while cortisol is still elevated. For the complete evidence breakdown, see our guide on how long ashwagandha takes to work.

Stacking ashwagandha with magnesium glycinate in the evening is a common approach, they work through complementary pathways (HPA axis modulation + GABA/melatonin support). More on this in our magnesium glycinate sleep guide.

5. Weight and Body Composition

Ashwagandha is not a weight loss supplement. But cortisol-driven weight gain, the visceral fat accumulation pattern, the stress eating, the stubborn midsection, is where it may help indirectly.

Choudhary et al. (2017) randomized 52 chronically stressed adults to 300 mg ashwagandha twice daily or placebo for 8 weeks. Body weight dropped. BMI dropped. Food cravings dropped. Serum cortisol dropped. Weight management benefit was mediated through cortisol reduction, not through any direct metabolic or thermogenic effect.

We wrote a dedicated piece on this: does ashwagandha cause weight gain? Short answer: no clinical evidence for fat gain. Only scenario where the scale might go up: lean muscle mass during resistance training (Wankhede et al. 2015).

6. Fertility. Mostly Mechanistic, Not Clinical

Let's be direct: there are no large RCTs testing ashwagandha's effect on female fertility outcomes (pregnancy rates, time-to-conception, IVF success). Nearly every "ashwagandha for women" article's fertility angle is almost entirely extrapolated from:

• Cortisol reduction → restored GnRH pulsatility → normalized ovulation (mechanistic)
• The Gopal 2021 perimenopause trial showing increased estradiol and decreased FSH/LH (not a fertility trial)
• Male fertility data (Ambiye et al. 2013 showed improved sperm parameters, different biology entirely)

If you're trying to conceive, ashwagandha might help if stress is actually disrupting your cycle. But it's not a fertility treatment and shouldn't be framed as one. And critically: ashwagandha should be discontinued once pregnant. More on safety below.

How much ashwagandha should women take?

Across most women-specific trials, the clinical standard is 300 mg twice daily (600 mg/day total) of a root extract standardized to ≥5% withanolides. That's the dose used in the Chandrasekhar cortisol trial, the Dongre sexual function trial, and the Langade sleep trial.

Gopal's perimenopause study also used 300 mg twice daily, but with a different extract. Results are broadly consistent because the active compound class (withanolides) is the same.

Our ashwagandha dosage guide covers the full protocol. Quick summary for women:

Not all ashwagandha products are equivalent. Here's how the most popular brands compare:

Our take: if you want the extract with the most published clinical data behind it, KSM-66® is the obvious choice. Jarrow uses KSM-66 but at half the clinical dose (300 mg vs 600 mg), you'd need two capsules. NOW Foods uses a generic extract at lower withanolide concentration. Gaia doesn't standardize to withanolide content at all, which makes dose-response comparison impossible. For timing specifics, see best time to take ashwagandha.

How Long Does Ashwagandha Take to Work for Women?

Women's ashwagandha evidence spans three domains: cortisol and stress (the 27.9% reduction in PMID 23439798 was gender-inclusive), perimenopausal symptoms (trials show hot flash and mood improvements at 300–600 mg/day), and sleep quality. The hard exclusion is pregnancy — ashwagandha's uterine-stimulant properties make it contraindicated.

Don't expect a dramatic overnight shift. Ashwagandha recalibrates your HPA axis gradually, which is actually better than a fast-acting anxiolytic, because the effect doesn't wear off when you miss a dose. Our full timeline breakdown: how long does ashwagandha take to work.

What are ashwagandha's side effects, and who should avoid it?

For women specifically, ashwagandha trials document reduced perceived stress, improved perimenopausal hot flashes and mood, and better sleep scores at 300–600 mg/day of standardized extract. The cortisol mechanism (27.9% reduction, PMID: 23439798) applies across sexes. Pregnancy is the absolute contraindication; thyroid medication users need monitoring since ashwagandha can raise T3/T4.

Do NOT take ashwagandha if you are:

• Pregnant or trying to become pregnant, animal studies suggest potential abortifacient effects. No human safety data in pregnancy. Stop taking it once you start trying to conceive.
• Breastfeeding — insufficient safety data. Not worth the unknown risk.
• Diagnosed with hyperthyroidism or Graves' disease, ashwagandha may stimulate thyroid hormone production (Sharma et al. 2018 showed increased T3 and T4 in subclinical hypothyroid patients). For women with overactive thyroid, this could be dangerous.
• On thyroid medication (levothyroxine), potential interaction. Consult your endocrinologist.
• On immunosuppressants — ashwagandha has immunomodulatory properties that could interfere.
• On sedatives or anti-anxiety medications, additive effects possible.

Does ashwagandha interact with medications?

What did the 2026 overcorrection case report show?

A case report published in early 2026 in PMC described a 55-year-old postmenopausal woman who developed adrenal insufficiency after chronic ashwagandha use for osteoarthritis pain (PMC). She presented with Cushingoid features and low basal cortisol, the ACTH stimulation test confirmed her adrenals had essentially been suppressed.

This is a single case report. It doesn't invalidate the broader safety profile. But it illustrates a real risk: if you take ashwagandha long-term at high doses and your cortisol drops too far, your HPA axis may downregulate its own cortisol production. Clinical trials run 8–12 weeks. Long-term safety data beyond 12 weeks is thin.

Practical advice: cycle it. 8 weeks on, 2–4 weeks off. Or use it during high-stress periods rather than indefinitely. If you experience unusual fatigue, dizziness upon standing, or unexplained weight changes after months of use, get your cortisol checked.

Can Women Take Ashwagandha Daily?

Yes. Most trials dosed ashwagandha daily for 8 to 16 weeks with a good safety record in women. Longer continuous use is less studied. It should be avoided in pregnancy and used cautiously with thyroid or autoimmune conditions, so periodic breaks and a doctor's input for ongoing use are sensible.

Yes, assuming you're not in any of the contraindicated groups above. All the clinical trials used daily dosing. But daily doesn't mean forever. Trials lasted 8–12 weeks, and that's the evidence window we have. Taking breaks (2–4 weeks off every 2–3 months) is a reasonable precaution given the 2026 adrenal insufficiency case report.

Start at 300 mg once daily for the first week to assess tolerance, then increase to 300 mg twice daily. Take it with food — withanolides are fat-soluble, and absorption improves with a meal. For a complete comparison of KSM-66 versus generic extracts, see our KSM-66 vs regular ashwagandha breakdown.

Is ashwagandha good for PMS?

There's no RCT specifically testing ashwagandha for premenstrual syndrome. But the mechanism is plausible: cortisol reduction → less HPA axis interference with the luteal phase → potentially milder PMS symptoms. Women with stress-exacerbated PMS (the kind that's worse during busy months) are the most likely to benefit.

Kernodle OB-GYN published a clinical blog recommending ashwagandha as part of a PMS management approach, and their page ranks in Google's top 15 with just 5 referring domains. That tells you the search intent is real even though the research is still catching up.

If PMS is your primary concern, ashwagandha is a reasonable addition to your toolkit, but it's not replacing magnesium (which has stronger PMS evidence), exercise, or medical evaluation for severe PMDD.

Our Batch-Level Purity Testing

Manufactured in a UL Solutions GMP-certified facility (Retail Certification Program Requirements, certification valid through November 12, 2028). Every batch of Ashwagandha Plus undergoes independent third-party testing at a cGMP-compliant third-party laboratory for heavy metals and microbial contamination. Lot 5100117 (COA issued 01/16/2026) passed every safety threshold.

Testing performed using validated analytical methods per cGMP requirements. The data below reflects batch-specific results — not general ingredient claims — verified under current Good Manufacturing Practices (21 CFR Part 111).

Testing performed by cGMP-compliant third-party laboratory. Serving size: 2 Capsules. Manufacturing date: 10/15/2025. Full batch results: yourhealthier.com/pages/lab-results. Original certificates of analysis available upon request.

Authoritative Resources

For independent, government-reviewed information on this ingredient, consult these primary sources:

• NCCIH — Ashwagandha

Testing & Transparency Methodology

Every YourHealthier product referenced here is manufactured in an FDA-registered facility and undergoes independent third-party testing at accredited laboratories (ISO/IEC 17025, A2LA, or Eurofins, depending on the product). Each batch is screened for heavy metals (lead, cadmium, mercury, arsenic) and microbial contamination (total plate count, yeast, mold, E. coli, Salmonella) using validated USP, AOAC, and ICP-MS methods. Batch-specific certificates of analysis are published at yourhealthier.com/pages/lab-results and updated with each new manufacturing run. All testing complies with current Good Manufacturing Practices (21 CFR Part 111). This article is written for general educational purposes and is not medical advice; it has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.

References

1. Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). "A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults." Indian Journal of Psychological Medicine, 34(3), 255–262. PubMed
2. Al-Daghri, N.M., et al. (2025). "Effects of Ashwagandha Supplements on Cortisol, Stress, and Anxiety Levels in Adults: A Systematic Review and Meta-Analysis." Nutrients. PMC
3. Gopal, S., et al. (2021). "Effect of an ashwagandha (Withania Somnifera) root extract on climacteric symptoms in women during perimenopause." Journal of Obstetrics and Gynaecology Research, 47(12), 4414–4425. PubMed
4. Dongre, S., Langade, D., & Bhattacharyya, S. (2015). "Efficacy and Safety of Ashwagandha Root Extract in Improving Sexual Function in Women: A Pilot Study." BioMed Research International, 2015, 284154. PMC
5. Langade, D., Thakare, V., Kanchi, S., & Kelgane, S. (2021). "Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients." Journal of Ethnopharmacology, 264, 113276. PubMed
6. Lopresti, A.L., Smith, S.J., Malvi, H., & Kodgule, R. (2019). "An investigation into the stress-relieving and pharmacological actions of an ashwagandha extract." Medicine, 98(37), e17186. PMC
7. Case report. (2026). "From herbal hope to hormonal havoc: chronic ashwagandha use and HPA axis suppression." Cureus. PMC
8. Brendler, T. (2025). "Evaluation of Potential Hormonal Activities of Ashwagandha (Withania somnifera)." Phytotherapy Research. PubMed

---

Is Ashwagandha Safe While Breastfeeding?

No reliable safety data exists. No human studies have tested whether ashwagandha's withanolides transfer into breast milk or affect a nursing infant. The Natural Medicines Database rates it possibly unsafe during lactation due to insufficient evidence. The standard recommendation is to avoid it while nursing. Discuss alternatives like magnesium glycinate or L-theanine, which have better-established lactation safety, with your lactation consultant.

This article is for informational purposes only and is not intended as medical advice. Always consult your healthcare provider before starting any new supplement.

Disclosure: YourHealthier sells ashwagandha (KSM-66®). We've been upfront about where the evidence is strong and where it's limited, including the fertility section, where we told you the clinical data in women barely exists. If we just wanted to sell capsules, we'd skip that part. See our Editorial Policy.

Does Ashwagandha Make You Sleepy?

Ashwagandha can promote sleepiness, and this is partly by design. A 2019 double-blind RCT found that 300 mg of ashwagandha root extract twice daily significantly improved sleep quality and reduced sleep onset latency compared to placebo in adults with insomnia (Langade et al., 2019, PMID: 31728244). The mechanism involves GABAergic activity: the withanolide triethylene glycol in ashwagandha modulates GABA receptors, the same neurotransmitter system targeted by sleep medications. For women using ashwagandha for stress or cortisol management, this mild sedative effect is often a benefit, not a side effect. If daytime drowsiness is a concern, take your dose in the evening rather than the morning, or reduce to 300 mg/day. The sleep-promoting effect tends to be mild at standard doses and is well below the sedation level of pharmaceutical sleep aids.

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not intended as medical advice.

Ashwagandha for Women

Metric	Value
Cortisol reduction	27.9%
RCTs in 2025 meta	873 adults
Perimenopause dose (Gopal 2021)	300 mg × 2
Daily dose (KSM-66)	300–600 mg
Source: YourHealthier · 2025 meta (15 RCTs); Gopal 2021

Chart: Ashwagandha for Women. Data: Cortisol reduction: 27.9%; RCTs in 2025 meta: 873 adults; Perimenopause dose (mg x2): Gopal 2021; Daily dose (mg): KSM-66. Source: 2025 meta (15 RCTs); Gopal 2021.